Averin Capital Acquisition appoints Akiko Moni Miyashita to its board of directors
Averin Capital Acquisition Corp., a special purpose acquisition company (SPAC), appointed Akiko Moni Miyashita to its board effective immediately on May 28, 2026. She is a former Valo Health and IBM corporate strategy and M&A executive, and she signed a joinder to the company's February 18, 2026 letter agreement, which includes redemption waivers and voting commitments for an initial business combination.
Key points
- Board appointment made May 28, 2026, effective immediately; Ms. Miyashita will serve in the first class of directors until the first annual general meeting.
- Ms. Miyashita, age 70, is founder of Beacon Hill Strategy Group and previously served as Executive Vice President and Chief Strategy Officer of Valo Health, LLC (May 2019 to September 2024).
- She signed a joinder to the February 18, 2026 letter agreement, under which signatories agreed to waive certain redemption rights and vote in favor of an initial business combination.
- She also signed a joinder to the February 18, 2026 registration rights agreement and entered into a standard director indemnity agreement.
The filing
Written by AI on Nov 9, 2026, 11:48 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 29, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.